Todd Kelsey Sells 1,500 Shares of Plexus (NASDAQ:PLXS) Stock

Plexus Corp. (NASDAQ:PLXS) CEO Todd Kelsey sold 1,500 shares of the business’s stock in a transaction dated Wednesday, May 20th. The stock was sold at an average price of $252.77, for a total value of $379,155.00. Following the completion of the sale, the chief executive officer directly owned 72,388 shares of the company’s stock, valued at $18,297,514.76. This represents a 2.03% decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan.

Plexus Trading Up 3.6%

Plexus stock opened at $265.72 on Friday. The company has a debt-to-equity ratio of 0.06, a quick ratio of 0.74 and a current ratio of 1.54. The business’s 50-day simple moving average is $230.26 and its 200-day simple moving average is $190.15. The firm has a market capitalization of $7.11 billion, a PE ratio of 38.85 and a beta of 0.88. Plexus Corp. has a 52 week low of $115.35 and a 52 week high of $275.83.

Plexus (NASDAQ:PLXS) last posted its quarterly earnings data on Wednesday, April 29th. The technology company reported $2.05 EPS for the quarter, topping analysts’ consensus estimates of $1.87 by $0.18. The business had revenue of $1.16 billion for the quarter, compared to analyst estimates of $1.13 billion. Plexus had a return on equity of 12.84% and a net margin of 4.35%.The firm’s revenue for the quarter was up 18.7% on a year-over-year basis. During the same period in the previous year, the company posted $1.66 earnings per share. Plexus has set its Q3 2026 guidance at 2.020-2.180 EPS. Equities research analysts forecast that Plexus Corp. will post 5.98 earnings per share for the current year.

Hedge Funds Weigh In On Plexus

Several institutional investors and hedge funds have recently added to or reduced their stakes in PLXS. AQR Capital Management LLC increased its stake in Plexus by 103.1% during the first quarter. AQR Capital Management LLC now owns 8,384 shares of the technology company’s stock valued at $1,074,000 after acquiring an additional 4,255 shares during the period. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. increased its stake in Plexus by 4.6% during the first quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 15,971 shares of the technology company’s stock valued at $2,046,000 after acquiring an additional 705 shares during the period. United Services Automobile Association bought a new position in Plexus during the first quarter valued at about $218,000. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC grew its stake in shares of Plexus by 12.9% in the 1st quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 79,584 shares of the technology company’s stock valued at $10,197,000 after purchasing an additional 9,078 shares during the period. Finally, Cetera Investment Advisers bought a new stake in shares of Plexus in the 2nd quarter valued at approximately $309,000. 94.45% of the stock is currently owned by institutional investors.

Analyst Upgrades and Downgrades

A number of research firms have recently commented on PLXS. Zacks Research lowered Plexus from a “hold” rating to a “strong sell” rating in a research note on Wednesday. Weiss Ratings upgraded Plexus from a “buy (b-)” rating to a “buy (b)” rating in a research note on Monday, May 11th. Raymond James Financial reiterated an “outperform” rating and issued a $275.00 price objective on shares of Plexus in a research note on Thursday, April 30th. Benchmark reiterated a “buy” rating and issued a $220.00 price objective on shares of Plexus in a research note on Monday, March 16th. Finally, Wall Street Zen upgraded Plexus from a “hold” rating to a “buy” rating in a research note on Saturday, May 2nd. Five research analysts have rated the stock with a Buy rating, one has assigned a Hold rating and one has issued a Sell rating to the company. Based on data from MarketBeat.com, the stock presently has an average rating of “Moderate Buy” and an average target price of $229.17.

Key Stories Impacting Plexus

Here are the key news stories impacting Plexus this week:

• Positive Sentiment: Zacks Research raised its earnings estimates for Plexus across multiple future periods, including FY2026, FY2027, FY2028 and several quarterly forecasts. Higher earnings expectations can support the stock by reinforcing the view that Plexus’ growth and profitability are improving. Plexus earnings estimate updates
• Neutral Sentiment: An article referenced investor reaction to Plexus accelerating ultra-secure defense hardware development with Riverside Research, which suggests continued interest in its defense-related business, but the available details are limited. Investor reaction article
• Negative Sentiment: Zacks Research also downgraded Plexus to “Strong Sell”, which may weigh on sentiment despite its higher earnings forecasts. Zacks downgrade
• Negative Sentiment: Plexus CEO Todd Kelsey sold 1,500 shares in a pre-arranged Rule 10b5-1 transaction. While routine, insider selling can still create a small headwind for investor sentiment. SEC Form 4 filing

About Plexus

Plexus Corp. (NASDAQ: PLXS) is a global provider of electronics manufacturing services (EMS) and precision engineered electronics solutions. Headquartered in Neenah, Wisconsin, the company partners with original equipment manufacturers across industries such as medical, industrial, aerospace and defense, computing, and communications. Plexus offers a full suite of services that span new product introduction, product lifecycle management, supply chain management, printed circuit board assembly, system integration, and aftermarket support.

Founded in 1979, Plexus has grown from a regional electronics assembler into a multinational organization with manufacturing and engineering centers across North America, Europe, and Asia.